| abstract |
The invention relates to novel difluorphenyl diacylhydrazide derivates of formula I, where R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and R 7 have the meanings indicated in Claim 1, said derivates being kinase inhibitors and useable for treating illnesses and diseases such as diabetes, obesity, metabolic syndrome (dyslipidemia), systemic and pulmonary hypertension, cardiac circulatory diseases, and kidney diseases, in general for all types of fibroses, inflammatory processes, tumors, and tumor illnesses. |